Comprehensive Cancer Center

Vratsa 3001

0 studies enrolling now · 3 studies all time

What they study most

Castration-Resistant Prostatic Cancer, Metastatic Castration-sensitive Prostate Cancer, Metastatic Prostate Cancer

Studies at this site

• A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for Treatment of Participants With Metastatic Prostate Cancer — Running, not enrolling
• A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for the Treatment of Participants With Deleterious Germline or Somatic Homologous Recombination Repair (HRR) Gene-Mutated Metastatic Castration-Sensitive Prostate Cancer (mCSPC) — Running, not enrolling
• A Study to Determine Frequency of DNA-repair Defects in Men With Metastatic Prostate Cancer — Completed